Integrated multiomics analysis of chromosome 19 miRNA cluster in bladder cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Integrated multiomics analysis of chromosome 19 miRNA cluster in bladder cancer ; volume:23 ; number:3 ; day:5 ; month:8 ; year:2023 ; pages:1-17 ; date:9.2023
Functional & integrative genomics ; 23, Heft 3 (5.8.2023), 1-17, 9.2023
- Urheber
-
Ware, Akshay Pramod
Satyamoorthy, Kapaettu
Paul, Bobby
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10142-023-01191-0
- URN
-
urn:nbn:de:101:1-2023120808541951800267
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ware, Akshay Pramod
- Satyamoorthy, Kapaettu
- Paul, Bobby
- SpringerLink (Online service)
Ähnliche Objekte (12)
Selective activation of miRNAs of the primate-specific chromosome 19 miRNA cluster (C19MC) in cancer and stem cells and possible contribution to regulation of apoptosis
CmirC update 2024: a multi-omics database for clustered miRNAs
The role of TKS5 in bladder cancer and chromosome instability
Diagnostic and prognostic potential clustered miRNAs in bladder cancer
ChrXq27.3 miRNA cluster functions in cancer development
Overexpressed HSF1 cancer signature genes cluster in human chromosome 8q
BcCluster: A Bladder Cancer Database at the Molecular Level
Diet, gonadal sex, and sex chromosome complement influence white adipose tissue miRNA expression
FCMDAP: using miRNA family and cluster information to improve the prediction accuracy of disease related miRNAs
Detection of bladder, breast and prostate cancer using serum and tissue miRNA profiling
Detection of bladder, breast and prostate cancer using serum and tissue miRNA profiling
Epigenetic interplay between methylation and miRNA in bladder cancer: focus on isoform expression
Selective activation of miRNAs of the primate-specific chromosome 19 miRNA cluster (C19MC) in cancer and stem cells and possible contribution to regulation of apoptosis
CmirC update 2024: a multi-omics database for clustered miRNAs
The role of TKS5 in bladder cancer and chromosome instability
Diagnostic and prognostic potential clustered miRNAs in bladder cancer
ChrXq27.3 miRNA cluster functions in cancer development
Overexpressed HSF1 cancer signature genes cluster in human chromosome 8q
BcCluster: A Bladder Cancer Database at the Molecular Level
Diet, gonadal sex, and sex chromosome complement influence white adipose tissue miRNA expression
FCMDAP: using miRNA family and cluster information to improve the prediction accuracy of disease related miRNAs
Detection of bladder, breast and prostate cancer using serum and tissue miRNA profiling
Detection of bladder, breast and prostate cancer using serum and tissue miRNA profiling
Epigenetic interplay between methylation and miRNA in bladder cancer: focus on isoform expression
Selective activation of miRNAs of the primate-specific chromosome 19 miRNA cluster (C19MC) in cancer and stem cells and possible contribution to regulation of apoptosis
CmirC update 2024: a multi-omics database for clustered miRNAs
The role of TKS5 in bladder cancer and chromosome instability
Diagnostic and prognostic potential clustered miRNAs in bladder cancer
ChrXq27.3 miRNA cluster functions in cancer development
Overexpressed HSF1 cancer signature genes cluster in human chromosome 8q
BcCluster: A Bladder Cancer Database at the Molecular Level
Diet, gonadal sex, and sex chromosome complement influence white adipose tissue miRNA expression
FCMDAP: using miRNA family and cluster information to improve the prediction accuracy of disease related miRNAs
Detection of bladder, breast and prostate cancer using serum and tissue miRNA profiling
Detection of bladder, breast and prostate cancer using serum and tissue miRNA profiling